Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
ACRS on Nasdaq
Andrew Kenneth William Powell - trading volume in the past year for Aclaris Therapeutics, Inc.
Holdings reported by Andrew Kenneth William Powell for Aclaris Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
33.5K |
$42.2K |
$1.26 |
Jun 1, 2024 |
Direct |
|
|
| Restricted Stock Units |
0 |
$0 |
$1.26 |
Jun 1, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
15.8K |
|
|
Jun 1, 2023 |
Direct |
Common Stock |
|
Transactions reported by Andrew Kenneth William Powell for Aclaris Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.